News

CB03-154 is a newer ALS therapy that's designed to open nerve cells' KCNQ2 and KCNQ3 potassium channels without affecting ...
Columnist Kristin Neva says she's heard that some patients are being told they can't get feeding tubes until they have worsening problems.
Guest writer Anita Newton recounts her struggle to access help for her husband's ALS during the height of COVID-19 ...
KLTO‑202 is an experimental gene therapy that would deliver the instructions for a protein that may reduce inflammation and ...
A noninvasive therapy delivering gentle spinal stimulation was shown to slow disease progression and extend survival in an ...
A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn ...
A noninvasive therapy delivering gentle spinal stimulation was shown to slow disease progression and extend survival in an ALS mouse model.
A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn (debamestrocel).
Reflecting on a scary road rage incident reminds columnist Kristin Neva of the fragility of life. None of us is guaranteed tomorrow.
Megan Williams, whose father had ALS, shares what caregiving taught her about grief, planning, and honoring his end-of-life wishes with love.
ALS is challenging, but you are not alone: Our ALS community is here to support you with their tips, advice, and words of wisdom.